PA
TT icon

PharVision Advisers’s Trane Technologies TT Stock Holding History

PharVision Advisers’s Portfolio TT Stock Details TT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-996
Closed -$388K – 606
2025
Q4 		$388K Buy
+996
New +$412K 0.2% 142
2025
Q3 		– Sell
-601
Closed -$263K – 800
2025
Q2 		$263K Sell
601
-378
-39% -$149K 0.38% 116
2025
Q1 		$330K Sell
979
-185
-16% -$66.9K 0.46% 79
2024
Q4 		$430K Buy
+1,164
New +$462K 0.36% 67

Other funds holding TT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PharVision Advisers's TT Position: Q1 2026 in Review

PharVision Advisers sold out of Trane Technologies (TT) in Q1 2026, closing a stake of 996 shares — an estimated $388K sold.

PharVision Advisers first reported a position in TT in Q4 2024 and held it in 4 quarters. The position peaked at $430K in Q4 2024. 1,755 funds tracked by Wall St. Rank hold TT as of Q1 2026.

  • PharVision Advisers reported no remaining Trane Technologies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 996 Trane Technologies shares in Q1 2026, an estimated $388K.
  • PharVision Advisers first reported a position in Trane Technologies in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Trane Technologies position peaked at $430K in Q4 2024.
  • 1,755 funds tracked by Wall St. Rank held Trane Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.